Resources

Type of publications
Regions
Diseases
4864 results found
2024 ∙ ATAGI
ATAGI interim statement on the use of vaccines for prevention of mpox in 2024
Recommendation Western Pacific Australia Mpox
Download:
2024 ∙ ATAGI
ATAGI statement on the transition from quadrivalent to trivalent seasonal influenza vaccines in Australia
Recommendation Western Pacific Australia Influenza
Download:
2024 ∙ Su Hyun Lim, Mona Hersi, Ramya Krishnan, Joshua Montroy, Bonnie Rook, Kelly Farrah, Yung-En Chung, Adrienne Stevens, Joseline Zafack, Eva Wong, Nicole Forbes, April Killikelly, Kelsey Young, Matthew Tunis
COVID-19 vaccine evidence monitoring assisted by artificial Intelligence: An emergency system implemented by the Public Health Agency of Canada to capture and describe the trajectory of evolving pandemic vaccine literature
Americas Canada COVID-19
Download:
2024
CoPI - List of core members
Functioning Africa Mozambique health policy
Download:
2024 ∙ Yemane Berhane, Telahun Teka, Meseret Zelalem, Yohannes Lakew, Amha Mekasha, Bogale Worku, Genet G/Medhin, Liya Wassie, Liya Wondwossen, Mulat Nigus, Samuel Teshome, Shiferaw Mitiku, Solomon Tessema Memirie, Teferi Fenta, Workeabeba Abebe, Yirgu Gebrehiwot
The Ethiopian National Immunization Technical Advisory Group (E-NITAG): Establishment, Achievements and the Future
Functioning Africa Ethiopia
Download:
2024 ∙ NIAC
NIAC updated recommendations for COVID-19 primary schedule vaccination
Recommendation Europe Ireland COVID-19
Download:
2024 ∙ ACIP
Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices ― United States, 2023
Recommendation Americas United States of America Meningococcal disease
Download:
2024 ∙ ACIP
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–25 Influenza Season
Recommendation Americas United States of America Influenza
Download:
2024 ∙ ACIP
Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the ACIP — United States, 2024
Recommendation Americas United States of America older adults RSV (Respiratory syncytial virus)
Download:
2024 ∙ ACIP
ACIP Evidence to Recommendations for Use of Protein Subunit RSV vaccines (GSK Arexvy or Pfizer Abrysvo) in All Adults Aged ≥75 years and in Adults Aged 60–74 at Increased Risk of Severe RSV Disease
Background paper Americas United States of America older adults EtR framework RSV (Respiratory syncytial virus)
Loading...